Fig. 1From: Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trialsParticipant flow diagram. LTF, lost to follow-up; ITT, intent-to-treat; mITT, modified intent-to-treat; TIR, triptan insufficient responder; WOC, withdrawal of consent. aThis analysis did not include the ubrogepant 100 mg arm from the ACHIEVE I trial. bThis analysis did not include the ubrogepant 25 mg arm from the ACHIEVE II trialBack to article page